PL375834A1 - Chronoterapeutyczne preparaty diltiazemu i ich podawanie - Google Patents
Chronoterapeutyczne preparaty diltiazemu i ich podawanieInfo
- Publication number
- PL375834A1 PL375834A1 PL03375834A PL37583403A PL375834A1 PL 375834 A1 PL375834 A1 PL 375834A1 PL 03375834 A PL03375834 A PL 03375834A PL 37583403 A PL37583403 A PL 37583403A PL 375834 A1 PL375834 A1 PL 375834A1
- Authority
- PL
- Poland
- Prior art keywords
- chronotherapeutic
- administration
- diltiazem formulations
- diltiazem
- formulations
- Prior art date
Links
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 title 1
- 229960004166 diltiazem Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40887202P | 2002-09-09 | 2002-09-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL375834A1 true PL375834A1 (pl) | 2005-12-12 |
Family
ID=31978692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL03375834A PL375834A1 (pl) | 2002-09-09 | 2003-09-09 | Chronoterapeutyczne preparaty diltiazemu i ich podawanie |
Country Status (10)
Country | Link |
---|---|
US (2) | US7348028B2 (pl) |
EP (1) | EP1545476A4 (pl) |
JP (1) | JP2006501261A (pl) |
AU (1) | AU2003270349A1 (pl) |
CA (1) | CA2496837A1 (pl) |
MX (1) | MXPA05002623A (pl) |
NO (1) | NO20051190L (pl) |
NZ (1) | NZ539174A (pl) |
PL (1) | PL375834A1 (pl) |
WO (1) | WO2004022038A1 (pl) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8778395B2 (en) * | 2005-08-11 | 2014-07-15 | Andrx Labs, Llc | Diltiazem controlled release formulation and method of manufacture |
WO2010105673A1 (en) * | 2009-03-18 | 2010-09-23 | Evonik Röhm Gmbh | Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising a polymer mixture and excipients |
PL2408436T3 (pl) * | 2009-03-18 | 2017-08-31 | Evonik Röhm Gmbh | Kompozycja farmaceutyczna o kontrolowanym uwalnianiu z odpornością na wpływ etanolu, wykorzystująca powłokę zawierającą neutralne polimery winylowe i zaróbki |
US8927010B2 (en) | 2011-03-23 | 2015-01-06 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US11241391B2 (en) | 2011-03-23 | 2022-02-08 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US8916588B2 (en) | 2011-03-23 | 2014-12-23 | Ironshore Pharmaceuticals & Development, Inc. | Methods for treatment of attention deficit hyperactivity disorder |
US9603809B2 (en) | 2011-03-23 | 2017-03-28 | Ironshore Pharmaceuticals & Development, Inc. | Methods of treatment of attention deficit hyperactivity disorder |
US10905652B2 (en) | 2011-03-23 | 2021-02-02 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US10292937B2 (en) | 2011-03-23 | 2019-05-21 | Ironshore Pharmaceuticals & Development, Inc. | Methods of treatment of attention deficit hyperactivity disorder |
MX357551B (es) | 2011-03-23 | 2018-07-13 | Ironshore Pharmaceuticals & Dev Inc | Metodos y composiciones para el tratamiento de trastorno por deficit de atencion. |
US9283214B2 (en) | 2011-03-23 | 2016-03-15 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US9119809B2 (en) | 2011-03-23 | 2015-09-01 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US9498447B2 (en) | 2011-03-23 | 2016-11-22 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5364620A (en) * | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
IE56999B1 (en) * | 1983-12-22 | 1992-03-11 | Elan Corp Plc | Pharmaceutical formulation |
FR2623714B1 (fr) * | 1987-11-26 | 1990-04-20 | Ethypharm Sa | Forme a liberation prolongee du diltiazem, et son medicament ainsi obtenu |
US5344657A (en) * | 1988-04-27 | 1994-09-06 | Elf Sanofi | Microbeads of diltiazem, a process for their manufacture and a substained-release pharmaceutical composition containing them |
US5288505A (en) * | 1991-06-26 | 1994-02-22 | Galephar P.R., Inc., Ltd. | Extended release form of diltiazem |
US5229135A (en) * | 1991-11-22 | 1993-07-20 | Prographarm Laboratories | Sustained release diltiazem formulation |
US5376384A (en) * | 1992-12-23 | 1994-12-27 | Kinaform Technology, Inc. | Delayed, sustained-release pharmaceutical preparation |
US6524620B2 (en) * | 1998-07-20 | 2003-02-25 | Andrx Pharmaceuticals, Inc. | Diltiazem controlled release formulation and method of manufacture |
US7108866B1 (en) | 1999-12-10 | 2006-09-19 | Biovall Laboratories International Srl | Chronotherapeutic diltiazem formulations and the administration thereof |
-
2003
- 2003-09-09 NZ NZ539174A patent/NZ539174A/en unknown
- 2003-09-09 AU AU2003270349A patent/AU2003270349A1/en not_active Abandoned
- 2003-09-09 US US10/657,752 patent/US7348028B2/en not_active Expired - Fee Related
- 2003-09-09 MX MXPA05002623A patent/MXPA05002623A/es not_active Application Discontinuation
- 2003-09-09 CA CA002496837A patent/CA2496837A1/en not_active Abandoned
- 2003-09-09 EP EP03752036A patent/EP1545476A4/en not_active Withdrawn
- 2003-09-09 PL PL03375834A patent/PL375834A1/pl not_active Application Discontinuation
- 2003-09-09 WO PCT/US2003/027895 patent/WO2004022038A1/en active Application Filing
- 2003-09-09 JP JP2004534664A patent/JP2006501261A/ja active Pending
-
2005
- 2005-03-04 NO NO20051190A patent/NO20051190L/no not_active Application Discontinuation
-
2007
- 2007-12-07 US US11/952,343 patent/US20090118256A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004022038A1 (en) | 2004-03-18 |
MXPA05002623A (es) | 2005-05-05 |
US7348028B2 (en) | 2008-03-25 |
EP1545476A1 (en) | 2005-06-29 |
US20040176352A1 (en) | 2004-09-09 |
CA2496837A1 (en) | 2004-03-18 |
EP1545476A4 (en) | 2008-01-09 |
US20090118256A1 (en) | 2009-05-07 |
NZ539174A (en) | 2007-05-31 |
AU2003270349A1 (en) | 2004-03-29 |
NO20051190L (no) | 2005-04-08 |
JP2006501261A (ja) | 2006-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL388076A1 (pl) | Doustna postać dawki o przedłużonym uwalnianiu oksykodonu i jej zastosowanie | |
ZA200502495B (en) | Ester compound and medicinal use thereof. | |
HK1068555A1 (en) | New formulations and use thereof | |
IL168784A (en) | Fused 1,3-dihydroimidazole ring compounds and pharmaceutical compositions comprising the same | |
IL159532A0 (en) | Enteral formulations | |
HK1065257A1 (en) | Medicinal composition | |
EP1545476A4 (en) | CHRONOTHERAPEUTIC DILTIAZEM PREPARATIONS AND THEIR ADMINISTRATION | |
EP1370240A4 (en) | NEUROPROTECTOR FORMULATIONS AND METHOD | |
AU2000231564A1 (en) | Phosphororganic compounds and the use thereof | |
AU5713400A (en) | The health mask | |
GB0114746D0 (en) | Medicinal composition | |
GB2386580B (en) | The bricky's mate | |
GB0128138D0 (en) | Pharmaceutical use | |
GB0212233D0 (en) | The chair pinnie | |
GB0004777D0 (en) | The duckbill | |
GB0018001D0 (en) | 1,25-Dihydroxy-5,6-trans Vitamin D3,and the use thereof | |
CA91654S (en) | Chair | |
CA91530S (en) | Chair | |
CA91529S (en) | Chair | |
CA91652S (en) | Chair | |
AU2002256588A1 (en) | Catalase-inactivating compounds and the use thereof | |
GB0301635D0 (en) | "The Floor" | |
GB0126680D0 (en) | Pharmacopoeia | |
GB9910914D0 (en) | The chair | |
GB0125582D0 (en) | Fotwear designs 4 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |